IQVIA ranked among the top searched stocks for 2 days in the past month.

As of 2:31 PM on the 26th, IQVIA is trading at 44,450 KRW, down 5.63% from the previous day. This represents a 30.44% decline compared to June 24. IQVIA is known as a company possessing core technology in transdermal drug delivery systems.

Over the past 5 days, individual investors have net purchased 110,379 shares, while foreign investors and institutions have net sold 29,161 shares and 55,961 shares, respectively.

On June 25, IQVIA became a market issue with the headline "Did the positive news of joint development with Celltrion fade? Sudden plunge."

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing